Abstract
Pericentric heterochromatin silencing at mammalian centromeres is essential for mitotic fidelity and genomic stability. Defective pericentric silencing has been observed in senescent cells, aging tissues, and mammalian tumors, but the underlying mechanisms and functional consequences of these defects are unclear. Here, we uncover an essential role of the human SIRT6 enzyme in pericentric transcriptional silencing, and we show that this function protects against mitotic defects, genomic instability, and cellular senescence. At pericentric heterochromatin, SIRT6 promotes deacetylation of a new substrate, residue K18 of histone H3 (H3K18), and inactivation of SIRT6 in cells leads to H3K18 hyperacetylation and aberrant accumulation of pericentric transcripts. Strikingly, depletion of these transcripts through RNA interference rescues the mitotic and senescence phenotypes of SIRT6-deficient cells. Together, our findings reveal a new function for SIRT6 and regulation of acetylated H3K18 at heterochromatin, and demonstrate the pathogenic role of deregulated pericentric transcription in aging- and cancer-related cellular dysfunction.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Sirt6 attenuates chondrocyte senescence and osteoarthritis progression
Nature Communications Open Access 10 December 2022
-
Epigenetic regulation of aging: implications for interventions of aging and diseases
Signal Transduction and Targeted Therapy Open Access 07 November 2022
-
Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression
Nature Communications Open Access 20 July 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout




Accession codes
Change history
15 April 2009
In the version of this article initially published online, acknowledgement of funding support for K.F.C. by a sponsored research agreement with Daiichi Sankyo Co., Inc. had been omitted, and a positive competing financial interest statement had not been included. The errors have been corrected for the print, PDF and HTML versions of this article.
References
De Cecco, M. et al. Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 12, 247–256 (2013).
De Cecco, M. et al. Transposable elements become active and mobile in the genomes of aging mammalian somatic tissues. Aging (Albany, N.Y.) 5, 867–883 (2013).
Ting, D.T. et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 331, 593–596 (2011).
Shumaker, D.K. et al. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc. Natl. Acad. Sci. USA 103, 8703–8708 (2006).
Shah, P.P. et al. Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev. 27, 1787–1799 (2013).
Kugel, S. & Mostoslavsky, R. Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem. Sci. 39, 72–81 (2014).
Mostoslavsky, R. et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315–329 (2006).
Zhong, L. et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140, 280–293 (2010).
Kim, H.S. et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 12, 224–236 (2010).
Sebastián, C. et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185–1199 (2012).
Xiao, C. et al. Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J. Biol. Chem. 287, 41903–41913 (2012).
Masri, S. et al. Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158, 659–672 (2014).
Kanfi, Y. et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218–221 (2012).
Lin, Z. et al. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. Cell Rep. 5, 1639–1649 (2013).
Lerrer, B., Gertler, A.A. & Cohen, H.Y. The complex role of SIRT6 in carcinogenesis. Carcinogenesis 37, 108–118 (2015).
Sharma, A. et al. The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J. Biol. Chem. 288, 18439–18447 (2013).
Michishita, E. et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492–496 (2008).
Michishita, E. et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8, 2664–2666 (2009).
Yang, B., Zwaans, B.M., Eckersdorff, M. & Lombard, D.B. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 8, 2662–2663 (2009).
Tennen, R.I., Bua, D.J., Wright, W.E. & Chua, K.F. SIRT6 is required for maintenance of telomere position effect in human cells. Nat. Commun. 2, 433 (2011).
Kawahara, T.L. et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62–74 (2009).
Sundaresan, N.R. et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat. Med. 18, 1643–1650 (2012).
McCord, R.A. et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany, N.Y.) 1, 109–121 (2009).
Toiber, D. et al. SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Mol. Cell 51, 454–468 (2013).
Kaidi, A., Weinert, B.T., Choudhary, C. & Jackson, S.P. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329, 1348–1353 (2010).
Mao, Z. et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443–1446 (2011).
Dominy, J.E. Jr. et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell 48, 900–913 (2012).
Van Meter, M. et al. SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat. Commun. 5, 5011 (2014).
Jiang, H. et al. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496, 110–113 (2013).
Eymery, A. et al. A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells. Nucleic Acids Res. 37, 6340–6354 (2009).
González-Barrios, R., Soto-Reyes, E. & Herrera, L.A. Assembling pieces of the centromere epigenetics puzzle. Epigenetics 7, 3–13 (2012).
Gil, R., Barth, S., Kanfi, Y. & Cohen, H.Y. SIRT6 exhibits nucleosome-dependent deacetylase activity. Nucleic Acids Res. 41, 8537–8545 (2013).
Valgardsdottir, R. et al. Structural and functional characterization of noncoding repetitive RNAs transcribed in stressed human cells. Mol. Biol. Cell 16, 2597–2604 (2005).
Martens, J.H. et al. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24, 800–812 (2005).
Peters, A.H. et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323–337 (2001).
Rowbotham, S.P. et al. Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1. Mol. Cell 42, 285–296 (2011).
Briers, S., Crawford, C., Bickmore, W.A. & Sutherland, H.G. KRAB zinc-finger proteins localise to novel KAP1-containing foci that are adjacent to PML nuclear bodies. J. Cell Sci. 122, 937–946 (2009).
Zeng, L. et al. Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing. Nat. Struct. Mol. Biol. 15, 626–633 (2008).
Li, Y. et al. AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation. Cell 159, 558–571 (2014).
Grewal, S.I. RNAi-dependent formation of heterochromatin and its diverse functions. Curr. Opin. Genet. Dev. 20, 134–141 (2010).
Bühler, M. & Moazed, D. Transcription and RNAi in heterochromatic gene silencing. Nat. Struct. Mol. Biol. 14, 1041–1048 (2007).
Maison, C. et al. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet. 30, 329–334 (2002).
Rudd, N.L., Williams, S.E., Evans, M., Hennig, U.G. & Hoar, D.I. Kinetochore analysis of micronuclei allows insights into the actions of colcemid and mitomycin C. Mutat. Res. 261, 57–68 (1991).
Zhu, Q. et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477, 179–184 (2011).
Wang, Z. et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40, 897–903 (2008).
Barber, M.F. et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114–118 (2012).
Oberdoerffer, P. et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135, 907–918 (2008).
Pinheiro, I. et al. Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell 150, 948–960 (2012).
Zhang, W. et al. Aging stem cells: a Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. Science 348, 1160–1163 (2015).
Boyarchuk, E., Filipescu, D., Vassias, I., Cantaloube, S. & Almouzni, G. The histone variant composition of centromeres is controlled by the pericentric heterochromatin state during the cell cycle. J. Cell Sci. 127, 3347–3359 (2014).
Bunch, H. et al. TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release. Nat. Struct. Mol. Biol. 21, 876–883 (2014).
Endisha, H. et al. Restoring SIRT6 expression in Hutchinson-Gilford progeria syndrome cells impedes premature senescence and formation of dysmorphic nuclei. Pathobiology 82, 9–20 (2015).
Todaro, G.J. & Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299–313 (1963).
Valgardsdottir, R. et al. Transcription of Satellite III non-coding RNAs is a general stress response in human cells. Nucleic Acids Res. 36, 423–434 (2008).
Michishita, E., Park, J.Y., Burneskis, J.M., Barrett, J.C. & Horikawa, I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 16, 4623–4635 (2005).
Dahl, J.A. & Collas, P. A quick and quantitative chromatin immunoprecipitation assay for small cell samples. Front. Biosci. 12, 4925–4931 (2007).
Ohzeki, J. et al. Breaking the HAC barrier: histone H3K9 acetyl/methyl balance regulates CENP-A assembly. EMBO J. 31, 2391–2402 (2012).
Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Chen, K. et al. DANPOS: dynamic analysis of nucleosome position and occupancy by sequencing. Genome Res. 23, 341–351 (2013).
Chan, F.L. et al. Active transcription and essential role of RNA polymerase II at the centromere during mitosis. Proc. Natl. Acad. Sci. USA 109, 1979–1984 (2012).
Dimri, G.P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363–9367 (1995).
Acknowledgements
We thank O. Gozani and members of the laboratories of K.F.C. and O. Gozani for useful discussions, and S. Paredes, T. Hong, and L.D. Boxer for technical assistance. We thank X. Shi (University of Texas M.D. Anderson Cancer Center) for providing bacterial expression vectors for the AF9 YEATS domain and Z. Yang (Stanford University) for KAP1 expression vectors. This work was supported by grants from the US National Institutes of Health (NIH) to K.F.C. (R01 AG028867, R56AG050997), the Department of Veterans Affairs to K.F.C. (Merit Award), the Paul F. Glenn Laboratories for the Biology of Aging (K.F.C.), and fellowship awards to L.T. (Italian Foundation for Cancer Research fellowship abroad, American Italian Cancer Foundation postdoctoral research fellowship, and Stanford Dean's fellowship) and to Z.O. (Walter and Idun Berry postdoctoral fellowship). Work in the laboratory of W.L. was funded in part by grants from the Cancer Prevention Research Institute of Texas (RP150292) and the NIH (R01HG007538 and R01CA193466). Research of K.F.C. is partly funded by Daiichi Sankyo Co., Inc.
Author information
Authors and Affiliations
Contributions
L.T. and K.F.C. conceived the project, designed the experiments and wrote the manuscript. L.T. performed in vitro and cellular deacetylation assays, ChIP and ChIP–seq experiments, RNA expression analysis, microscopy, and cell biology experiments. Y.X. and W.L. performed bioinformatic analyses for the ChIP–seq experiments and contributed to the corresponding manuscript sections. W.Z. performed ChIP experiments in KAP1-depleted cells and contributed to analysis of KAP1 in SIRT6-depleted cells. R.I.T. contributed to the deacetylation assay on H3K18ac peptides, analysis of satellite transcripts, and manuscript editing. Z.O. performed ChIP experiments in SIRT6-overexpressing cells. F.S. purified nucleosomes for deacetylation assays.
Corresponding authors
Ethics declarations
Competing interests
Research of K.F.C. is partly funded by Daiichi Sankyo Co., Inc.
Integrated supplementary information
Supplementary Figure 1 H3K18ac is a physiologic SIRT6 substrate.
(a) Western analysis showing H3K18Ac levels on purified calf thymus histone H3 after in vitro deacetylation assay. Reactions with or without NAD+, control GSTprotein, wild type GST-SIRT6 (GST-SIRT6 WT) or the catalytically inactive GST-SIRT6 H133Y mutant protein (GST-SIRT6 HY) are indicated. Total H3 is shown as loading control. Results are representative of 3 independent experiments. (b) Additional exposures of western blots showing H3K18Ac, H3K9Ac and H3K56Ac levels in SIRT6 KO MEFs compared to WT littermate control MEFs presented in Figure 3d (litter1), and western analysis on lysates from a second set of WT and SIRT6 KO littermate MEF lines (litter 2).
Supplementary Figure 2 SIRT6 selectively regulates H3K18 deacetylation at pericentric chromatin.
(a) Genome-wide peak profile analysis of H3K18Ac ChIP-seq reads within ±1Kb flanking TSS’s in SIRT6 knockdown (KD1) and control cells (two-tailed Student’s t-test, n=22198 peaks). (b) Genome-wide peak profiles of H3K9Ac and H3K56Ac ChIP-seq reads showing average occupancy within 100Kb windows from centromeric gaps (Pericentric) (two-tailed Student’s t-test, n=488 peaks for H3K9Ac, n=500 peaks for H3K56Ac). (c) H3K18Ac ChIP-seq enrichment at families of repetitive DNA elements annotated in Repbase in SIRT6 KD1 versus control cells. (d) ChIP-seq H3K18Ac levels at several centric consensus (CTcons1, CTcons2) or the indicated chromosome-specific centric (CT) sequences. Graph shows values of forward and reverse paired-end reads (r1 and r2) normalized to control. (e) Western blot showing Flag-SIRT6 levels in U2OS cells transfected with SIRT6 wild type (WT), catalytic mutant (SIRT6 HY), or empty control vectors for ChIP experiments in (f). β-tubulin, loading control. (f, g) H3K9Ac and H3K56Ac ChIP-qPCR in U2OS cells after SIRT6 overexpression (f) or knock-down (g) at pericentric repeats (Sat II, Sat III) or chromosome-specific centric α-satellite repeats (17a, 21a, 21b, Xa). Control, 5S ribosomal DNA (5SR) repeats. In (f), data represent mean +/- s.e.m. of n=3 independent cell cultures. In (g), H3K9Ac data represent mean +/- s.e.m. of independent knockdown experiments (n=6 for Sat II, Sat III, Xa, and n=5 for 17a, 21a, 21b), for H3K56Ac (mean +/- s.e.m. of n=4 independent knockdown experiments for all sequences, except Xa where n=5). *p<0.05, when not indicated p>0.05 (one-tailed Student’s t-test).
Supplementary Figure 3 SIRT6 depletion disrupts silencing of pericentric chromatin and leads to aberrant accumulation of satellite transcripts.
(a) ChIP-qPCR for SIRT6 at pericentric satellite repeats (Sat II, Sat III), compared to positive control sequences (LINE1, RPL23 promoter DNA) and negative control sequence (Neg, Myosin-1 promoter) (mean +/- s.e.m. of n=3 technical replicates). Similar results were observed in 2 independent experiments. (b) Detection of Sat III transcripts from cytoplasmic (C) and nuclear (N) RNA by northern blot. HeLa cells heat shocked (H.S.) were used as positive control. Ethidium bromide staining is provided as loading control. Similar results were observed in 3 independent knockdown experiments. (c) Top, western analysis of SIRT7 levels in SIRT7-depleted (SIRT7 KD) U2OS cells. β-tubulin (β-tub), loading control. Bottom, qRT-PCR of Sat III transcripts (mean +/- s.e.m. of n=3 independent knockdown experiments). (d) ChIP-qPCR for H3K36me3 at pericentric repeats or control 5S ribosomal DNA (5SR) (mean +/- s.e.m. of n=3 technical replicates). Similar results were observed in 3 independent experiments. (e) ChIP-seq H3K9me3 levels at two pericentric consensus sequences (PCT cons1, PCT cons2) or at control 18S ribosomal DNA (18S). Graph shows average value of paired-end reads. (f) ChIP-qPCR showing HP1a enrichment (mean +/- s.e.m. of n=3 independent knockdown experiments). (g) Western analysis showing SIRT6 depletion in SIRT6 knock-out (KO) U2OS cells. H3, loading control. (h) Western blot showing KAP1 levels in U2OS KAP1 knockdown (KAP1 KD) cells. β-tub, loading control. (i) ChIP-qPCR for KAP1 and IgG control at pericentric satellite repeats and LINE1 sequences upon KAP1 knockdown. Actin promoter is shown as negative control (mean +/- s.e.m. of n=3 technical replicates). (j) ChIP-qPCR for H3K9me3 at pericentric repeats, and control sequences (LINE1), in KAP1 KD cells (mean +/- s.e.m. of n=3 independent knockdown experiments). In (a), (c), (d), (f), (i) and (j): *p<0.05; **p<0.01; ***p<0.001; when not indicated, p>0.05 (one-tailed Student’s t-test).
Supplementary Figure 4 Aberrant accumulation of pericentric satellite transcripts in SIRT6-deficient cells causes mitotic defects and cellular senescence.
(a) Representative image showing asymmetric mitosis in SIRT6 depleted (SIRT6 KD) cell. DNA was stained with DAPI (blue), microtubules with α-tubulin (green) and centrosomes with γ-tubulin (magenta). Bar, 5 μm. (b) Immunofluorescence showing SIRT6 KD cells with micronuclei (arrows), and micronuclei containing centromeres (detected by anticentromere CREST antibodies). Bar, 10 μm. (c) Quantitative RT–PCR of Satellite III transcript and SIRT6 mRNA levels in cells used in Figure 4e,h. U2OS cells were transiently transfected with combinations of siRNAs specific for SIRT6 (siSIRT6), Sat III transcripts (siSat III), and negative control siRNAs (–) as indicated (mean +/- s.d. of n=3 technical replicates). The results are representative of 3 independent knockdown experiments. (d) Senescence-associated β-galactosidase (SA-β-gal) activity assay. Representative image of U2OS cells quantified in Figure 4h. Bar, 25 μm. (e) Left, representative images of SA-β-galactosidase assays in Sat III overexpressing (Sat III OE) or control cells. Right, quantification of SA-β-gal positive cells (mean +/- s.e.m. of n=5 quantifications, for a total of > 2000 cells scored per sample). Experiment is representative of 2 independent biological replicates. (f) Left, SA-β-galactosidase assay images of SIRT6 depleted HeLa and A549 cells. Percentages (%) of SA-β-gal positive cells (mean +/- s.e.m. of n=5 quantifications) are indicated on the representative images. Bar, 25 μm. Right, levels of Sat III transcripts determined by qRT–PCR (mean +/- s.e.m. of n=3 independent knockdown experiments). (g) Top, qRT–PCR of Satellite III transcripts in SIRT6-deficient A549 cells co-depleted of Sat III transcripts. Bottom, quantification of SA-β-gal positive cells (mean +/- s.e.m. of n=5 quantifications). The results are representative of 2 independent knockdown experiments. In all panels, *p<0.05; **p<0.01; ***p<0.001; and when not indicated, p>0.05 (two-tailed Student’s t-test).
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4 and Supplementary Tables 1 and 2 (PDF 23380 kb)
Supplementary Data Set 1
Uncropped blots (PDF 23663 kb)
Rights and permissions
About this article
Cite this article
Tasselli, L., Xi, Y., Zheng, W. et al. SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence. Nat Struct Mol Biol 23, 434–440 (2016). https://doi.org/10.1038/nsmb.3202
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.3202
This article is cited by
-
Sirt6-mediated epigenetic modification of DNA accessibility is essential for Pou2f3-induced thymic tuft cell development
Communications Biology (2022)
-
Epigenetic regulation of aging: implications for interventions of aging and diseases
Signal Transduction and Targeted Therapy (2022)
-
Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cells
Nature Communications (2022)
-
Sirt6 attenuates chondrocyte senescence and osteoarthritis progression
Nature Communications (2022)
-
Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression
Nature Communications (2022)